Sean Mackay
First SEC filing: Sept. 3, 2024 · Latest: Sept. 3, 2024
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 20, 2026 | LAB | F | 25,729 | $0.67 | $17,238 | 1,480,823 Direct | -1.71% | Disposed | 11.8% (price as of 2026-10-05) |
| June 20, 2026 | LAB | A | 500,000 | · | · | 1,506,552 Direct | +49.67% | Acquired | (price as of 2026-10-05) |
| May 20, 2026 | LAB | F | 25,729 | $1.00 | $25,729 | 1,006,552 Direct | -2.49% | Disposed | -25.1% (price as of 2026-10-05) |
| March 20, 2026 | LAB | A | 272,107 | · | · | 1,032,281 Direct | +35.80% | Acquired | (price as of 2026-10-05) |
| March 20, 2026 | LAB | A | 612,240 | · | · | 612,240 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 23, 2026 | LAB | F | 19,661 | $1.15 | $22,610 | 760,174 Direct | -2.52% | Disposed | -34.9% (price as of 2026-10-05) |
| Nov. 20, 2025 | LAB | F | 19,661 | $1.28 | $25,166 | 779,835 Direct | -2.46% | Disposed | -41.5% (price as of 2026-10-05) |
| Aug. 20, 2025 | LAB | F | 19,661 | $1.27 | $24,969 | 799,496 Direct | -2.40% | Disposed | -41.0% (price as of 2026-10-05) |
| May 28, 2025 | LAB | F | 23,919 | $1.09 | $26,072 | 819,157 Direct | -2.84% | Disposed | -31.3% (price as of 2026-10-05) |
| May 23, 2025 | LAB | S | 13,217 | $0.94 | $12,424 | 843,076 Direct | -1.54% | Disposed | -20.3% (price as of 2026-10-05) |
| May 22, 2025 | LAB | S | 12,536 | $1.00 | $12,536 | 856,293 Direct | -1.44% | Disposed | -25.1% (price as of 2026-10-05) |
| May 21, 2025 | LAB | S | 12,838 | $1.03 | $13,223 | 868,829 Direct | -1.46% | Disposed | -27.3% (price as of 2026-10-05) |
| March 21, 2025 | LAB | A | 422,500 | · | · | 422,500 Direct | · | Acquired | (price as of 2026-10-05) |
| March 21, 2025 | LAB | A | 281,667 | · | · | 881,667 Direct | +46.94% | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 20, 2026 | LAB | Stock Option (Right to buy) | Common Stock | $0.98 | March 20, 2036 | 612,240 | Acquired |
| March 21, 2025 | LAB | Stock Option (Right to Buy) | Common Stock | $1.21 | March 21, 2035 | 422,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $471,888 | · | $340,817 | $396,158 | $469,680 | · | $14,000 | $1,692,543 |
| 2024 | $293,576 | · | · | · | $122,979 | · | · | $3,177,155 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.